Skip to main content

Clear Solutions Labs seeks to benefit from the Basel Area

| News

Clear Solutions Labs seeks to benefit from the Basel Area

27.06.2023

The founders of Clear Solutions Laboratories are putting together a team of experts in the fields of biotechnology, pharmaceutical science and analytical biochemistry in Basel. With its analytical services, the company intends to support the research of biotech and pharmaceutical firms based in the local area.

Roman Mathaes, CEO Clear Solutions Laboratories (image: Clear Solutions Laboratories)

Clear Solutions Laboratories has opted to establish a presence in Basel. According to information from the company itself, the startup is pursuing the vision of achieving sustainable, organic growth in the Basel Area by assembling a “cross-functional team of world-class experts” in the fields of biotechnology, pharmaceutical science, and analytical biochemistry.

The company offers specialized analytical services and research support to biotech and pharmaceutical companies in Basel, throughout Switzerland and across the world. In so doing, the aim is to reduce development times and the cost of medicines.

Perfect ecosystem for innovative endeavors

“By fostering a collaborative environment and attracting top talent, we are committed to driving innovation and advancing scientific frontiers in the vibrant Basel life science ecosystem”, as Clear Solutions Laboratories explains. For the future growth of the business, the company has found “extremely supportive and strong partners” in the shape of the investment and innovation promotion agency Basel Area Business & Innovation, in addition to Economic Development Basel-StadtImmobilien Basel-Stadt and the Swiss Biotech Association. Basel Area Business & Innovation has, for example, supported Clear Solutions Laboratories in searching for lab premises.

According to CEO Roman Mathaes, the decision in favor of Basel was made owing to its “rich scientific heritage, world-class research facilities, and unparalleled expertise in the field of life sciences”, which makes Basel the “perfect ecosystem for our innovative endeavors”.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Forty51 Ventures invests to found Mysthera Therapeutics

Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided...
Read More

Spexis receives capital commitment of 2.5 million US dollars

Investors have made an additional capital commitment to Spexis AG, based in the Basel Area. With an extra 2.5 million...
Read More

Do you have a question? We'd like to hear from you.